These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27385215)

  • 1. CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells.
    Zaborsky N; Gassner FJ; Asslaber D; Reinthaler P; Denk U; Flenady S; Hofbauer JP; Danner B; Rebhandl S; Harrer A; Geisberger R; Greil R; Egle A
    Oncotarget; 2016 Aug; 7(31):49459-49469. PubMed ID: 27385215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
    Chen YT; Kung JT
    J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5(+) B cell expansion.
    Palmer VL; Nganga VK; Rothermund ME; Perry GA; Swanson PC
    BMC Immunol; 2015 Nov; 16():66. PubMed ID: 26537916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis.
    Gorini F; Azzimonti L; Delfanti G; Scarfò L; Scielzo C; Bertilaccio MT; Ranghetti P; Gulino A; Doglioni C; Di Napoli A; Capri M; Franceschi C; Caligaris-Cappio F; Ghia P; Bellone M; Dellabona P; Casorati G; de Lalla C
    Blood; 2017 Jun; 129(26):3440-3451. PubMed ID: 28465341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
    Gerth E; Mattner J
    Front Immunol; 2019; 10():1449. PubMed ID: 31293596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8
    Ghnewa YG; O'Reilly VP; Vandenberghe E; Browne PV; McElligott AM; Doherty DG
    Clin Immunol; 2017 Oct; 183():91-98. PubMed ID: 28780376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets.
    Stremmel C; Exley M; Balk S; Hohenberger W; Kuchroo VK
    Eur J Immunol; 2001 Sep; 31(9):2818-28. PubMed ID: 11536181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemia.
    Jadidi-Niaragh F; Jeddi-Tehrani M; Ansaripour B; Razavi SM; Sharifian RA; Shokri F
    Med Oncol; 2012 Dec; 29(5):3561-9. PubMed ID: 22669567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
    Sköld M; Faizunnessa NN; Wang CR; Cardell S
    J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
    Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
    Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1+ effector memory phenotype.
    Göthert JR; Eisele L; Klein-Hitpass L; Weber S; Zesewitz ML; Sellmann L; Röth A; Pircher H; Dührsen U; Dürig J
    Cancer Immunol Immunother; 2013 Nov; 62(11):1697-1709. PubMed ID: 24022692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD1d-restricted NKT cells: an interstrain comparison.
    Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
    J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKT Cells in Mice Originate from Cytoplasmic CD3-Positive, CD4
    Hu Z; Gu W; Wei Y; Liu G; Wu S; Liu T
    Sci Rep; 2019 Feb; 9(1):1874. PubMed ID: 30755654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1d expression as a prognostic marker for chronic lymphocytic leukemia.
    Anastasiadis A; Kotsianidis I; Papadopoulos V; Spanoudakis E; Margaritis D; Christoforidou A; Gouliamtzi S; Tsatalas C
    Leuk Lymphoma; 2014 Feb; 55(2):320-5. PubMed ID: 23668820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of a CD1d-mediated interaction between mast cells and NKT cells aggravates atherosclerosis.
    Kritikou E; van Duijn J; Nahon JE; van der Heijden T; Bouwman M; Groeneveldt C; Schaftenaar FH; Kröner MJ; Kuiper J; van Puijvelde GHM; Bot I
    Atherosclerosis; 2019 Jan; 280():132-139. PubMed ID: 30513408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
    Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
    Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bispecific Single-Domain Antibody Boosts Autologous Vγ9Vδ2-T Cell Responses Toward CD1d in Chronic Lymphocytic Leukemia.
    de Weerdt I; Lameris R; Ruben JM; de Boer R; Kloosterman J; King LA; Levin MD; Parren PWHI; de Gruijl TD; Kater AP; van der Vliet HJ
    Clin Cancer Res; 2021 Mar; 27(6):1744-1755. PubMed ID: 33451981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.